Where is the live CopyMark page for USPTO serial 76511005?

The live record is at https://getcopymark.com/trademark/76511005. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns AXIOM PHARMACEUTICAL CORPORATION?

According to the public USPTO record for serial number 76511005, the listed owner(s) include: AXIOM PHARMACEUTICAL CORPORATION, AXIOM PHARMACEUTICAL CORPORATION, AXIOM PHARMACEUTICAL CORPORATION.

What is USPTO serial number 76511005?

Serial number 76511005 is the USPTO application identifier for the mark AXIOM PHARMACEUTICAL CORPORATION. It is used to track examination, publication, and registration of this trademark.

What is the current status of AXIOM PHARMACEUTICAL CORPORATION?

AXIOM PHARMACEUTICAL CORPORATION (76511005) currently shows USPTO status code 713 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover AXIOM PHARMACEUTICAL CORPORATION?

The public record lists International Classes: 035, 040. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: AXIOM PHARMACEUTICAL CORPORATION Serial# 76511005 | status 713; last event C18. | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AXIOM PHARMACEUTICAL CORPORATION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Marina Solo

Michael K. Reicher Axiom Pharmaceutical Corporation616 N. North CourtSuite 120Palatine, IL 60047

Goods and services

Class	Description	Status	First use
035	DISTRIBUTORSHIP SERVICES FOR THIRD PARTIES FEATURING PHARMACEUTICAL PREPARATIONS, NAMELY, ANTIBIOTICS, NARCOTIC ANALGESICS, ANTI-INFECTIVE AND ANTI-TUBERCULAR DRUGS, ANTIHISTAMINES AND ANTIHISTAMINIC DECONGESTANTS, ANTITUSSIVES, AND STEROIDS FOR TREATMENT OF VARIOUS DISEASES	SECTION 18 - CANCELLED	Mar 11, 2003
040	MANUFACTURE OF PHARMACEUTICAL PREPARATIONS, NAMELY, ANTIBIOTICS, NARCOTIC ANALGESICS, ANTI-INFECTIVE AND ANTI-TUBERCULAR DRUGS, ANTIHISTAMINES AND ANTIHISTAMINIC DECONGESTANTS, ANTITUSSIVES, AND STEROIDS FOR TREATMENT OF VARIOUS DISEASES TO THE ORDER AND SPECIFICATION OF THIRD PARTIES	SECTION 18 - CANCELLED	Mar 11, 2003

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Nov 17, 2008	C18.	CANCELLED SECTION 18-TOTAL	—
Nov 17, 2008	CANT	CANCELLATION TERMINATED NO. 999999	—
Nov 7, 2008	CANG	CANCELLATION GRANTED NO. 999999	—
Jul 28, 2008	PETC	CANCELLATION INSTITUTED NO. 999999	—
Jun 7, 2005	R.PR	REGISTERED-PRINCIPAL REGISTER	Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 23, 2005	REGV	LAW OFFICE REGISTRATION REVIEW COMPLETED	—
Mar 14, 2005	ALIE	ASSIGNED TO LIE	—
Mar 6, 2005	CNPR	ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED	—
Nov 23, 2004	SUPC	STATEMENT OF USE PROCESSING COMPLETE	—
Nov 23, 2004	IUAF	USE AMENDMENT FILED	—
Nov 23, 2004	EISU	TEAS STATEMENT OF USE RECEIVED	The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Sep 14, 2004	NOAM	NOA MAILED - SOU REQUIRED FROM APPLICANT	A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 22, 2004	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 2, 2004	NPUB	NOTICE OF PUBLICATION	—
Apr 10, 2004	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Apr 7, 2004	CNEA	EXAMINERS AMENDMENT MAILED	—
Mar 10, 2004	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Mar 10, 2004	MAIL	PAPER RECEIVED	—
Sep 16, 2003	CNRT	NON-FINAL ACTION MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 5, 2003	DOCK	ASSIGNED TO EXAMINER	—

AXIOM PHARMACEUTICAL CORPORATION